Search results for "oligo"
Article
Ready for a strong start in oligo manufacturing?
Or are you already manufacturing your own oligos but are running into challenges? If so, we can help.
Fill in the form to discuss your needs with one of our specialists
Article
Are you ready to optimize your oligo synthesis?
Read it now to explore five key areas in your oligonucleotide chemistry where improvements will have a huge influence on the quality outcome of your synthesis.
Learn more
Article
Developing oligonucleotide therapeutics with confidence
You will learn about:
• the oligonucleotide therapeutic market
• the therapeutics in development
• challenges you may face and key considerations to address those challenges
• how to …
Article
Get a strong start in oligonucleotide manufacturing
Building on 40 years of experience, Cytiva launched ӒKTA oligosynt™ benchtop oligo synthesizer in 2022. It is the newest member of our oligo synthesizer family – a family of oligo systems that scales…
Article
Transformative Medicines Challenge FDA and Manufacturers
Biopharma researchers also are achieving success in developing oligonucleotide therapies, including antisense drugs and short interfering RNA treatments (siRNAs) that can modulate immune pathways. Saf…
Article
Get to know: oligonucleotide synthesis workflow
This free interactive course introduces you to synthetic oligonucleotides, applications they’re used in, and how they’re synthesized.
Take the course now
Article
Evolving demands of process development services
And, more recently, there has been a high demand for the CDMOs that can handle oligos, peptides, and various complex conjugates. Novel conjugates involving combinations of oligos, peptides, high poten…
Article
Enhancing Resins Addresses Purification Concerns
“This is why oligo(dT) support is often used in the purification of mRNA-based vaccines,” says Ihre.
The array of vaccine modalities that have been in development to address t…
Article
Working With Advanced Therapeutics: You Bring the Idea, We Bring the Map
Oligos. Cell and gene therapies. Antibody variants. Vaccines. We all know these advanced therapies hold huge potential. But developing them isn’t straightforward, and failing too late can be costly. A…
Article
How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug subs…